Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics
Sign Up to like & getrecommendations! Published in 2025 at "Advanced Healthcare Materials"
DOI: 10.1002/adhm.202404818
Abstract: Niclosamide, initially developed as an anthelmintic, has recently emerged as a potential antiviral, showing efficacy against diverse viral threats, including Mpox. As the global health landscape faces recurrent Mpox outbreaks, repurposing niclosamide through advanced material… read more here.
Keywords: nanohybridized niclosamide; mpox therapeutics; harnessing nanohybridized; precision mpox ... See more keywords